Company / PP&E (Net)
PULSE BIOSCIENCES, INC. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.1M
FY2025
5-year range
$1.1M / $2.5M
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#128 of 130
Health Care
What the data says
Among 130 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 2% for pp&e (net). PP&E (Net) has declined for 6 consecutive years, from $3M in FY2019 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -15.8%.
Declined from $2M to $1M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -18.8%
- 5-Year CAGR
- -15.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 130This company $1.1M Sector average $1.3B
▼
-99.9% below sector average
Key checks
Key Insights
- PULSE BIOSCIENCES, INC.'s pp&e (net) has declined for 6 consecutive years.
- 5-year CAGR of -15.8%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 9.4% year-over-year.
- Ranks #128 out of 130 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | -9.4% |
| FY2024 | $1.2M | -24.1% |
| FY2023 | $1.5M | -22.1% |
| FY2022 | $2.0M | -20.3% |
| FY2021 | $2.5M | -0.6% |
| FY2020 | $2.5M | -3.4% |
| FY2019 | $2.6M | +18.1% |
| FY2018 | $2.2M | -15.4% |
| FY2017 | $2.6M | +710.7% |
| FY2016 | $317.0K | -3.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026